Jazz Pharmaceuticals, Inc. (JAZZ) Price and Market Data

Jazz Pharmaceuticals, Inc. is an Ireland-based biopharmaceutical company focused mainly on therapies for sleep disorders and cancer. The company markets nine approved medicines across neuroscience and oncology, including Xyrem and Xywav for narcolepsy, Zepzelca for metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals, adding its flagship product Epidiolex, which is used to treat severe, rare forms of epilepsy.